BIOHLDG | BIOALPHA HOLDINGS BERHAD
0.020 (0.0%)
T-O (am): 0.000 (08:59:00)
Last updated: 10:36
BIOHLDG Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
BIOHLDG Quarter Reports
Customize
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28 Nov 25 | Q3 Sep 25 | 3 | 31 Dec 25 | 2.96 | -4.89 | -4.82 | -162.8% | 0.00 | -0.34 | 5.2% | 91.5% | 48.4% | 13.9% | ||||||||
| 28 Aug 25 | Q2 Jun 25 | 2 | 31 Dec 25 | 2.81 | -9.39 | -9.35 | -332.0% | 0.00 | -0.66 | 14.3% | 87.7% | 68.5% | 26.2% | ||||||||
| 30 May 25 | Q1 Mar 25 | 1 | 31 Dec 25 | 2.46 | -5.76 | -5.55 | -225.3% | 0.00 | -0.40 | 85.6% | 65.9% | 75.6% | 20.6% | ||||||||
| 28 Feb 25 | Q4 Dec 24 | 4 | 31 Dec 24 | 17.12 | -23.86 | -22.76 | -132.9% | 0.00 | -1.62 | 51.0% | 1.1% | 306.6% | 49.1% | ||||||||
| 29 Nov 24 | Q3 Sep 24 | 3 | 31 Dec 24 | 34.93 | -6.31 | -5.60 | -16.0% | 0.00 | -0.40 | 52.1% | 198.1% | 24.4% | 155.1% | ||||||||
| 30 Aug 24 | Q2 Jun 24 | 2 | 31 Dec 24 | 22.96 | -7.83 | -7.41 | -32.2% | 0.00 | -0.53 | 217.9% | 169.7% | 6.0% | 119.7% | ||||||||
| 31 May 24 | Q1 Mar 24 | 1 | 31 Dec 24 | 7.22 | -7.26 | -6.99 | -96.8% | 0.00 | -0.50 | 58.3% | 15.3% | 54.2% | 59.2% | ||||||||
| 29 Feb 24 | Q4 Dec 23 | 4 | 31 Dec 23 | 17.32 | -16.85 | -15.26 | -88.1% | 0.00 | -1.09 | 47.8% | 56.3% | 595.7% | 44.8% | ||||||||
| 30 Nov 23 | Q3 Sep 23 | 3 | 31 Dec 23 | 11.72 | -2.71 | -2.19 | -18.7% | 0.00 | -0.17 | 37.7% | 61.3% | 34.9% | 68.2% | ||||||||
| 30 Aug 23 | Q2 Jun 23 | 2 | 31 Dec 23 | 8.51 | -3.58 | -3.37 | -39.6% | 0.00 | -0.27 | 0.2% | 10.0% | 80.3% | 55.7% | ||||||||
| 31 May 23 | Q1 Mar 23 | 1 | 31 Dec 23 | 8.53 | -17.31 | -17.11 | -200.6% | 0.00 | -1.36 | 23.0% | 11.7% | 38.1% | 327.7% | ||||||||
| 28 Feb 23 | Q4 Dec 22 | 4 | 31 Dec 22 | 11.08 | -28.47 | -27.66 | -249.6% | 0.00 | -2.01 | 52.5% | 19.7% | 301.3% | 375.4% | ||||||||
| 29 Nov 22 | Q3 Sep 22 | 3 | 31 Dec 22 | 7.26 | -6.89 | -6.89 | -94.9% | 0.00 | -0.50 | 6.2% | 74.4% | 9.4% | 538.1% | ||||||||
| 30 Aug 22 | Q2 Jun 22 | 2 | 31 Dec 22 | 7.74 | -7.61 | -7.61 | -98.3% | 0.00 | -0.55 | 19.9% | 74.1% | 90.2% | 606.8% | ||||||||
| 31 May 22 | Q1 Mar 22 | 1 | 31 Dec 22 | 9.67 | -4.13 | -4.00 | -41.4% | 0.00 | -0.33 | 30.0% | 61.0% | 31.2% | 367.0% | ||||||||
| 28 Feb 22 | Q4 Dec 21 | 4 | 31 Dec 21 | 13.80 | -5.27 | -5.82 | -42.2% | 0.00 | -0.49 | 51.4% | 17.5% | 469.9% | 58.4% | ||||||||
| 25 Nov 21 | Q3 Sep 21 | 3 | 31 Dec 21 | 28.37 | 1.83 | 1.57 | 5.5% | 0.00 | 0.13 | 5.2% | 312.9% | 4.8% | 116.2% | ||||||||
| 01 Sep 21 | Q2 Jun 21 | 2 | 31 Dec 21 | 29.94 | 1.59 | 1.50 | 5.0% | 0.00 | 0.13 | 20.8% | 368.4% | 0.2% | 118.9% | ||||||||
| 27 May 21 | Q1 Mar 21 | 1 | 31 Dec 21 | 24.78 | 1.55 | 1.50 | 6.0% | 0.00 | 0.14 | 48.2% | 279.4% | 110.7% | 127.2% | ||||||||
| 02 Mar 21 | Q4 Dec 20 | 4 | 31 Dec 20 | 16.72 | -14.11 | -13.98 | -83.6% | 0.00 | -1.30 | 143.4% | 9.2% | 44.0% | 561.1% | ||||||||
| 27 Nov 20 | Q3 Sep 20 | 3 | 31 Dec 20 | 6.87 | -10.44 | -9.71 | -141.3% | 0.00 | -0.94 | 7.5% | 60.2% | 22.4% | 412.7% | ||||||||
| 28 Aug 20 | Q2 Jun 20 | 2 | 31 Dec 20 | 6.39 | -8.20 | -7.93 | -124.1% | 0.00 | -0.87 | 2.1% | 54.5% | 44.1% | 490.0% | ||||||||
| 25 Jun 20 | Q1 Mar 20 | 1 | 31 Dec 20 | 6.53 | -5.30 | -5.50 | -84.2% | 0.00 | -0.64 | 64.5% | 47.7% | 281.4% | 741.4% | ||||||||
| 28 Feb 20 | Q4 Dec 19 | 4 | 31 Dec 19 | 18.41 | 3.94 | 3.03 | 16.5% | 0.00 | 0.35 | 6.6% | 6.3% | 2.3% | 0.4% | ||||||||
| 28 Nov 19 | Q3 Sep 19 | 3 | 31 Dec 19 | 17.28 | 3.52 | 3.10 | 18.0% | 0.00 | 0.36 | 23.1% | 14.4% | 52.6% | 26.1% | ||||||||
| 30 Aug 19 | Q2 Jun 19 | 2 | 31 Dec 19 | 14.03 | 2.04 | 2.03 | 14.5% | 0.00 | 0.24 | 12.4% | 28.2% | 137.1% | 50.9% | ||||||||
| 27 May 19 | Q1 Mar 19 | 1 | 31 Dec 19 | 12.48 | 1.27 | 0.86 | 6.9% | 0.00 | 0.10 | 27.9% | 0.1% | 71.6% | 34.1% | ||||||||
| 28 Feb 19 | Q4 Dec 18 | 4 | 31 Dec 18 | 17.31 | 5.29 | 3.02 | 17.4% | 0.00 | 0.36 | 14.2% | 8.4% | 28.1% | 31.9% | ||||||||
| 26 Nov 18 | Q3 Sep 18 | 3 | 31 Dec 18 | 20.18 | 4.41 | 4.20 | 20.8% | 0.00 | 0.52 | 3.2% | 43.3% | 1.4% | 33.6% | ||||||||
| 23 Aug 18 | Q2 Jun 18 | 2 | 31 Dec 18 | 19.55 | 4.09 | 4.14 | 21.2% | 0.11 | 0.51 | 56.8% | 48.6% | 547.0% | 67.7% | ||||||||
| 28 May 18 | Q1 Mar 18 | 1 | 31 Dec 18 | 12.46 | 0.63 | 0.64 | 5.1% | 0.00 | 0.08 | 34.1% | 44.4% | 85.6% | 132.7% | ||||||||
| 26 Feb 18 | Q4 Dec 17 | 4 | 31 Dec 17 | 18.91 | 5.86 | 4.43 | 23.4% | 0.00 | 0.55 | 34.2% | 12.8% | 41.1% | 2.1% | ||||||||
| 27 Nov 17 | Q3 Sep 17 | 3 | 31 Dec 17 | 14.09 | 3.21 | 3.14 | 22.3% | 0.10 | 0.44 | 7.1% | 16.6% | 27.3% | 12.9% | ||||||||
| 23 Aug 17 | Q2 Jun 17 | 2 | 31 Dec 17 | 13.16 | 2.51 | 2.47 | 18.8% | 0.00 | 0.31 | 52.4% | 9.9% | 226.3% | 77.0% | ||||||||
| 30 May 17 | Q1 Mar 17 | 1 | 31 Dec 17 | 8.63 | -2.05 | -1.96 | -22.6% | 0.00 | -0.25 | 48.5% | 24.9% | 143.2% | 1702.5% | ||||||||
| 28 Feb 17 | Q4 Dec 16 | 4 | 31 Dec 16 | 16.76 | 3.94 | 4.53 | 27.0% | 0.00 | 0.68 | 38.7% | 72.7% | 62.8% | 18.2% | ||||||||
| 22 Nov 16 | Q3 Sep 16 | 3 | 31 Dec 16 | 12.09 | 2.72 | 2.78 | 23.0% | 0.00 | 0.54 | 1.0% | 41.6% | 99.4% | 9.0% | ||||||||
| 22 Aug 16 | Q2 Jun 16 | 2 | 31 Dec 16 | 11.97 | 1.38 | 1.40 | 11.7% | 0.00 | 0.28 | 73.2% | 45.0% | 1043.4% | 252.3% | ||||||||
| 27 May 16 | Q1 Mar 16 | 1 | 31 Dec 16 | 6.91 | 0.03 | 0.12 | 1.8% | 0.00 | 0.03 | 28.8% | 114.1% | 96.8% | 771.4% | ||||||||
| 26 Feb 16 | Q4 Dec 15 | 4 | 31 Dec 15 | 9.71 | 4.25 | 3.83 | 39.5% | 0.01 | 0.83 | 13.7% | 16.2% | 50.1% | 47.3% | ||||||||
| 27 Nov 15 | Q3 Sep 15 | 3 | 31 Dec 15 | 8.54 | 2.53 | 2.55 | 29.9% | 0.00 | 0.55 | 3.4% | 544.4% | ||||||||||
| 27 Aug 15 | Q2 Jun 15 | 2 | 31 Dec 15 | 8.25 | 0.50 | 0.40 | 4.8% | 0.00 | 0.09 | 155.8% | 2728.6% | ||||||||||
| 15 May 15 | Q1 Mar 15 | 1 | 31 Dec 15 | 3.23 | 0.01 | 0.01 | 0.4% | 0.00 | 0.00 | 61.4% | 99.5% | ||||||||||
| 09 Apr 15 | 31/12/14 | 4 | 31/12/14 | 8.35 | 2.70 | 2.60 | 31.1% | 0.13 | 0.72 |
BIOHLDG Historical Dividends
BIOHLDG Financial Ratios
| EPS | -3.02 sen |
| Trailing PE (Sector Median: 14.6) | 0.0 |
| PEG | 0.0 |
| Altman Z | -1.3 |
| Beaver | -0.394 |
| Current Ratio | 3.33 |
| Debt-Equity (DE) Ratio | 0.18 |
| FCF Yield | -21.49 % |
| Revenue QoQ | 5.15 % |
| Revenue YoY | -91.53% |
| Profit QoQ | 48.43 % |
| Profit YoY | 13.88 % |
| Profit Margin (Sector Median: 4.8) | -167.47 % |
| ROE (ROIC: -54.28) | -54.64 % |
| Dividend Per Share (DPS) | 0.0 sen |
| Dividend Yield (DY) | 0.0 % |
BIOHLDG Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 14.6) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 4.8) | |
| ROE (ROIC: -5.63) | |
| Altman Z |
BIOHLDG Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.06 | Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | -1.94 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0.0 |
| Expected Revenue (M) | 0.0 |
| Expected Growth (%) | 0.0 |
BIOHLDG Directors Share Purchases (Beta)
MR HON TIAN KOK @ WILLIAM added 90807.0 units announced on 30 Jun 2023 at ~RM0.09
MR HON TIAN KOK @ WILLIAM reduced 8775100.0 units announced on 22 Jul 2022 at ~RM0.13
MR HON TIAN [email protected] reduced 9335200.0 units announced on 14 Jul 2022 at ~RM0.135
MR HON TIAN [email protected] reduced 4931000.0 units announced on 08 Jul 2022 at ~RM0.13
MR HON TIAN [email protected] reduced 6206300.0 units announced on 01 Jul 2022 at ~RM0.145
MISS GOH SIOW CHENG reduced 3071600.0 units announced on 01 Jul 2022 at ~RM0.145
MISS GOH SIOW CHENG reduced 4928400.0 units announced on 29 Jun 2022 at ~RM0.15
MR HO TZE HIUNG reduced 8000000.0 units announced on 27 Jun 2022 at ~RM0.155
MR HON TIAN KOK @ WILLIAM added 8070900.0 units announced on 13 May 2022 at ~RM0.135
MR HON TIAN KOK @ WILLIAM added 3579200.0 units announced on 12 May 2022 at ~RM0.135
MR HON TIAN KOK @ WILLIAM added 1850000.0 units announced on 11 May 2022 at ~RM0.13
MR HON TIAN KOK @ WILLIAM added 1500000.0 units announced on 16 Mar 2022 at ~RM0.135
MR HON TIAN KOK @ WILLIAM added 13440735.0 units announced on 04 Mar 2022 at ~RM0.15
MR HON TIAN KOK @ WILLIAM added 138400.0 units announced on 29 Dec 2021 at ~RM0.185
MR HON TIAN [email protected] added 1866733.0 units announced on 05 Aug 2021 at ~RM0.21
MR HON TIAN [email protected] added 1000000.0 units announced on 10 Dec 2020 at ~RM0.285
ENCIK MOHD NASIR BIN ABDULLAH reduced 100000.0 units announced on 12 Nov 2020 at ~RM0.255
MOHD NASIR BIN ABDULLAH reduced 200000.0 units announced on 25 Aug 2020 at ~RM0.31
MR HO TZE HIUNG reduced 1000000.0 units announced on 03 Aug 2020 at ~RM0.285
BIOHLDG Summary
Market Cap: 28 M.
Market Cap Class: Shrimp
Number of Shares: 1406 M.
Adjusted Float: 67.0%.
Stock highly correlated with
SAMCHEM (92%)
GENTING (91%)
N2N (89%)
ASIAFLE (88%)
Bioalpha Holdings Berhad, incorporated in 2011 and headquartered in Kajang, Malaysia, is an integrated health supplement company specializing in the manufacturing, distribution, and retailing of nutraceutical and functional food products. The company operates across the entire value chain, encompassing herbal cultivation, research and development (R&D), manufacturing, trading, and retail pharmacy operations under the Constant Pharmacy brand. Bioalpha’s product portfolio includes herbal and non-herbal health supplements, functional foods, and traditional medicines, produced under both original design manufacturing (ODM) and proprietary house brands. The company also engages in herbal farming, operating MyGAP-certified herbal parks in Terengganu and Johor to ensure a stable supply of raw materials. Expanding regionally, Bioalpha has established a strong presence in Malaysia, Indonesia, and China, leveraging strategic partnerships, sustainable sourcing, and digital transformation initiatives. With a commitment to quality, innovation, and ESG-driven strategies, Bioalpha Holdings Berhad continues to strengthen its position in the health and wellness industry across key markets.
Sectors: Penny Stocks, Trading & Services, Food & Beverages, Consumer Products & Services
Share Registrar: PROSEC SHARE REGISTRATION SDN. BHD.
Code: 0179
Website: http://www.bioa.com.my/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
| Symbol | Price | Ex.Price | Premium | Expiry |
|---|---|---|---|---|
| BIOHLDG-WB | 0.01 | 0.1 | 450.0% | 05-Feb-2027 |
BIOHLDG Top Shareholdings
Updated on 31-Mar-2023
Frequently Asked Questions
BIOALPHA HOLDINGS BERHAD Latest News
BIOHLDG Insights+
Some features of iSaham Insights are exclusively available to iSaham Pro clients.
Learn More about iSaham ProResearch House Target Price
Average Target Price: N/A
Entitlements
(Bonus Issue, Share Split or Share consolidation for the past 3 years)
| Ex-Date | Category | Entitlements |
|---|---|---|
| No entitlements detected |
Private Placements
(Fund raising via private placement shares for the past 3 years)
| Date | Stage | Purpose | Issue Price |
|---|---|---|---|
| No Private Placements detected |